Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 10.24%181.97M | 28.39%461.4M | 31.07%165.06M | -40.62%359.37M | -51.52%125.94M | -25.57%605.21M | --259.77M | 10.79%813.18M | 9.58%734M | 6.03%669.85M |
| Operating income | 10.24%181.97M | 28.39%461.4M | 31.07%165.06M | -40.62%359.37M | -51.52%125.94M | -25.57%605.21M | 259.77M | 10.79%813.18M | 9.58%734M | 6.03%669.85M |
| Cost of sales | -8.98%-141.63M | -31.00%-349.7M | -68.10%-129.96M | 43.32%-266.95M | 60.00%-77.31M | 26.87%-470.99M | ---193.27M | -20.99%-644.01M | -7.43%-532.29M | 1.57%-495.47M |
| Operating expenses | -8.98%-141.63M | -31.00%-349.7M | -68.10%-129.96M | 43.32%-266.95M | 60.00%-77.31M | 26.87%-470.99M | -193.27M | -20.99%-644.01M | -7.43%-532.29M | 1.57%-495.47M |
| Gross profit | 14.92%40.34M | 20.86%111.7M | -27.82%35.1M | -31.14%92.42M | -26.88%48.63M | -20.66%134.22M | 66.51M | -16.13%169.17M | 15.67%201.71M | 35.80%174.38M |
| Selling expenses | -46.59%-40.53M | 4.99%-76.75M | 24.83%-27.65M | 16.21%-80.78M | 8.62%-36.78M | -31.95%-96.4M | ---40.25M | 1.49%-73.06M | -16.81%-74.16M | 7.79%-63.49M |
| Administrative expenses | 4.40%-21.29M | -10.47%-43.4M | -41.40%-22.27M | 27.79%-39.28M | 38.48%-15.75M | -23.63%-54.41M | ---25.6M | -101.27%-44.01M | -8.23%-21.87M | -8.29%-20.2M |
| Research and development expenses | 18.30%-21.65M | -25.74%-54.11M | -3.97%-26.49M | -13.47%-43.03M | -57.35%-25.48M | 13.56%-37.92M | ---16.19M | -45.21%-43.87M | 17.07%-30.21M | -56.85%-36.43M |
| Revaluation surplus | 93.89%-671K | 34.92%-12.44M | 45.75%-10.98M | -195.05%-19.12M | 57.64%-20.24M | -24.53%20.11M | ---47.79M | --26.65M | ---- | ---- |
| -Changes in the fair value of financial assets | 93.89%-671K | ---- | 45.75%-10.98M | ---- | 57.64%-20.24M | ---- | ---47.79M | --26.65M | ---- | ---- |
| -Changes in the fair value of other assets | ---- | 34.92%-12.44M | ---- | -195.05%-19.12M | ---- | --20.11M | ---- | ---- | ---- | ---- |
| Impairment and provision | -72.16%-5.34M | -3.81%-3.79M | -55.23%-3.1M | -117.51%-3.65M | ---2M | ---1.68M | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -72.16%-5.34M | -3.81%-3.79M | -55.23%-3.1M | -117.51%-3.65M | ---2M | ---1.68M | ---- | ---- | ---- | ---- |
| Special items of operating profit | -49.97%5.29M | -45.14%18.28M | -59.75%10.57M | -29.04%33.32M | 55.36%26.26M | 26.09%46.95M | --16.9M | 34.53%37.23M | 21.00%27.67M | 85.61%22.87M |
| Operating profit | 2.17%-43.85M | -0.64%-60.51M | -76.71%-44.82M | -653.48%-60.12M | 45.37%-25.36M | -84.94%10.86M | -46.43M | -30.09%72.11M | 33.73%103.15M | 157.17%77.13M |
| Financing cost | -11.97%-1.05M | -68.83%-2M | -303.45%-936K | -783.58%-1.18M | -141.67%-232K | -52.27%-134K | ---96K | 75.49%-88K | 70.74%-359K | 72.88%-1.23M |
| Earning before tax | 1.88%-44.9M | -1.96%-62.51M | -78.77%-45.76M | -671.42%-61.31M | 44.98%-25.6M | -85.10%10.73M | -46.52M | -29.93%72.03M | 35.41%102.79M | 198.03%75.91M |
| Tax | -85.74%79K | 122.83%2.56M | 104.48%554K | -91.21%-11.23M | -398.89%-12.35M | -158.03%-5.87M | --4.13M | 193.92%10.12M | -66.51%-10.78M | -578.27%-6.47M |
| After-tax profit from continuing operations | 0.85%-44.82M | 17.36%-59.94M | -19.12%-45.2M | -1,593.78%-72.54M | 10.47%-37.95M | -94.09%4.86M | -42.39M | -10.72%82.15M | 32.52%92.01M | 158.87%69.44M |
| Earning after tax | 0.85%-44.82M | 17.36%-59.94M | -19.12%-45.2M | -1,593.78%-72.54M | 10.47%-37.95M | -94.09%4.86M | -42.39M | -10.72%82.15M | 32.52%92.01M | 158.87%69.44M |
| Minority profit | -167.67%-356K | -25.11%-1.37M | 44.58%-133K | -209.07%-1.09M | -169.66%-240K | ---353K | ---89K | ---- | ---- | ---- |
| Profit attributable to shareholders | 1.35%-44.46M | 18.01%-58.58M | -19.52%-45.07M | -1,471.61%-71.45M | 10.85%-37.71M | -93.66%5.21M | -42.3M | -10.72%82.15M | 32.52%92.01M | 158.87%69.44M |
| Basic earnings per share | -0.96%-0.1368 | 15.37%-0.1767 | -25.46%-0.1355 | -1,357.83%-0.2088 | 28.24%-0.108 | -94.32%0.0166 | -0.1505 | -99.68%0.2922 | 28.57%90 | 70 |
| Diluted earnings per share | -0.96%-0.1368 | 15.37%-0.1767 | -25.46%-0.1355 | -4,361.22%-0.2088 | 28.24%-0.108 | -97.39%0.0049 | -0.1505 | -99.79%0.1877 | 28.57%90 | 70 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.